234 results on '"Qin, Juan‐Juan"'
Search Results
2. Resolution of inflammation, an active process to restore the immune microenvironment balance: A novel drug target for treating arterial hypertension
3. Macrophage neogenin deficiency exacerbates myocardial remodeling and inflammation after acute myocardial infarction through JAK1-STAT1 signaling
4. DEL-1 deficiency aggravates pressure overload-induced heart failure by promoting neutrophil infiltration and neutrophil extracellular traps formation
5. Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients
6. The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19
7. Kidney Function Indicators Predict Adverse Outcomes of COVID-19
8. Association of insulin resistance with bone mineral density in a nationwide health check-up population in China
9. Redefining cardiac biomarkers in predicting mortality of inpatients with COVID-19
10. Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes
11. In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19
12. Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19
13. The effect of multimorbidity patterns on physical and cognitive function in diabetes patients: a longitudinal cohort of middle-aged and older adults in China
14. Global death burden and attributable risk factors of peripheral artery disease by age, sex, SDI regions, and countries from 1990 to 2030: Results from the Global Burden of Disease study 2019
15. Kielin/chordin‐like protein deficiency aggravates pressure overload‐induced cardiac dysfunction and remodeling via P53/P21/CCNB1 signaling in mice
16. Extracorporeal Membrane Oxygenation Therapy for Critically Ill Coronavirus Disease 2019 Patients in Wuhan, China: A Retrospective Multicenter Cohort Study
17. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
18. Dynamic Prediction of Latent Shock Based on Machine Learning in Emergency Department: A Retrospective Study
19. Resolvin E1/ChemR23 Protects Against Hypertension and Vascular Remodeling in Angiotensin II–Induced Hypertensive Mice
20. Resolvin D1 attenuates Ang II-induced hypertension in mice by inhibiting the proliferation, migration and phenotypic transformation of vascular smooth muscle cells by blocking the RhoA/mitogen-activated protein kinase pathway
21. Caspase recruitment domain 6 protects against hepatic ischemia/reperfusion injury by suppressing ASK1
22. Influence of magnetic field on dynamic behavior of double-diffusive convection.
23. Maresin‐1 ameliorates hypertensive vascular remodeling through its receptor LGR6.
24. The association between outdoor air pollution and body mass index, central obesity, and visceral adiposity index among middle-aged and elderly adults: a nationwide study in China
25. Comparative impacts of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality
26. Prevalence and trend of atrial fibrillation and its associated risk factors among the population from nationwide health check-up centers in China, 2012–2017
27. Lipoprotein(a) distribution and its association with carotid arteriopathy in the Chinese population
28. Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality
29. Response by Zhang et al to Letter Regarding Article, “Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19”
30. The rising death burden of atrial fibrillation and flutter in low-income regions and younger populations
31. Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in China
32. Hepatic Oncostatin M Receptor β Regulates Obesity-Induced Steatosis and Insulin Resistance
33. The projections of global and regional rheumatic heart disease burden from 2020 to 2030
34. The prevalence of MAFLD and its association with atrial fibrillation in a nationwide health check-up population in China
35. The global disease burden attributable to a diet low in fibre in 204 countries and territories from 1990 to 2019
36. Global disease burden of stroke attributable to high fasting plasma glucose in 204 countries and territories from 1990 to 2019: An analysis of the Global Burden of Disease Study
37. Interferon Regulatory Factor 4 Inhibits Neointima Formation by Engaging Krüppel-Like Factor 4 Signaling
38. The global disease burden attributable to a diet low in fibre in 204 countries and territories from 1990 to 2019.
39. A Bidirectional Relationship Between Hyperuricemia and Metabolic Dysfunction-Associated Fatty Liver Disease
40. Projection of global burden and risk factors for aortic aneurysm – timely warning for greater emphasis on managing blood pressure
41. High Remnant Cholesterol Level Potentiates the Development of Hypertension
42. Distribution and Discordance of Updated GFR Estimating Equations in the Chinese Population
43. Heavy Disease Burden of High Systolic Blood Pressure During 1990-2019: Highlighting Regional, Sex, and Age Specific Strategies in Blood Pressure Control
44. Attenuation of cerebral ischemic injury in interferon regulatory factor 3-deficient rat
45. Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease
46. A risk score based on baseline risk factors for predicting mortality in COVID-19 patients
47. Redefining cardiac biomarkers in predicting mortality and adverse outcomes of inpatients with COVID-19
48. Global and Regional Trends and Projections of Infective Endocarditis-Associated Disease Burden and Attributable Risk Factors from 1990 to 2030
49. REPLY
50. No significant association between dipeptidyl peptidase-4 inhibitors and adverse outcomes of COVID-19
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.